HEPATITIS B ANTIBODY TITRE

The term “Hepatitis B antibody titre” refers to the quantitative measurement of antibodies against the Hepatitis B virus (HBV) in the blood. Specifically, it assesses the concentration of hepatitis B surface antibodies (anti-HBs), providing insights into the strength of the immune response. This measurement is particularly relevant in evaluating the effectiveness of Hepatitis B vaccination, helping healthcare professionals determine whether an individual has achieved sufficient immunity. Periodic testing of antibody titres may be recommended to assess the need for booster vaccinations, especially in certain high-risk groups. Decisions regarding vaccination strategies and interpretation of antibody titres should be discussed with healthcare providers to account for individual health considerations and potential risk factors.